2nd Edition of International Conference on Gastroenterology
Industries
🏥 Healthcare
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to 2nd Edition of International Conference on Gastroenterology — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
🔒 Get my buyer details Free · ~20 seconds
About this event
2nd Edition of International Conference on Gastroenterology
Date: September 24-26, 2026
Venue: Delta Hotels Heathrow Windsor, Ditton Rd, Langley, Slough SL3 8PT, United Kingdom
City/Country: London, UK
Event Type: Hybrid (In-person and Virtual)
Event Overview: The 2nd Edition of the International Conference on Gastroenterology (Gastro 2026) is a premier hybrid event that brings together gastroenterologists, hepatologists, clinical researchers, academicians, and healthcare practitioners from around the globe. This conference will focus on "Global Perspectives in Gastroenterology: Innovation to Impact," highlighting key areas of interest and current advancements in the field.
Who Attends (Buyers/Attendees)
This conference is attended by a diverse range of professionals, including:
- Gastroenterologists
- Hepatologists
- Clinical Researchers
- Academicians
- Healthcare Practitioners
The event attracts both in-person attendees in London, UK, and virtual participants from various regions, making it a globally accessible platform for knowledge exchange.
Location and Geographic Origin of Attendees
Event Location: Delta Hotels Heathrow Windsor, London, UK
Attendee Geographic Origin: Global, with a strong presence from Europe, North America, and Asia. The hybrid format allows for broader geographic reach, enabling professionals from various countries to participate virtually.
Audience Reach
Reach Type: Global
This conference has a global audience reach, attracting participants from diverse geographic regions. The hybrid format enhances accessibility, allowing professionals worldwide to engage with the latest research and innovations in gastroenterology.
Sample Buyer Company Names and Websites
| Priority | Company | Website | Best Title to Target | Why This is a Good Buyer Fit |
|---|---|---|---|---|
| 1 | Mayo Clinic | https://www.mayoclinic.org/ | Gastroenterology Department Head | Leading medical center with a strong focus on gastroenterology research and patient care. |
| 2 | Johns Hopkins Medicine | https://www.hopkinsmedicine.org/ | Director of Gastroenterology | Prominent institution in gastrointestinal research and clinical practice. |
| 3 | GlaxoSmithKline (GSK) | https://www.gsk.com/ | Research Manager, Gastrointestinal Therapeutics | Pharmaceutical company with active research in GI disorders and treatments. |
| 4 | Abbott Laboratories | https://www.abbott.com/ | Product Manager, Diagnostic Solutions | Company involved in diagnostic tools for gastrointestinal diseases. |
| 5 | University of California, San Francisco (UCSF) | https://www.ucsf.edu/ | Professor of Gastroenterology | Academic institution with significant contributions to GI research and education. |
| 6 | Novartis Pharmaceuticals | https://www.novartis.com/ | Director, GI Drug Development | Pharmaceutical company with a focus on developing treatments for gastrointestinal diseases. |
| 7 | Boston Scientific | https://www.bostonscientific.com/ | Product Development Manager, Endoscopy | Manufacturer of medical devices, including endoscopic solutions for GI procedures. |
| 8 | University of Oxford | https://www.ox.ac.uk/ | Research Fellow, Gastroenterology | Prestigious university conducting research in various aspects of gastrointestinal health. |
| 9 | Pfizer Inc. | https://www.pfizer.com/ | Senior Research Scientist, GI Immunology | Global pharmaceutical company involved in research and development of GI treatments. |
| 10 | Stanford University School of Medicine | https://medicine.stanford.edu/ | Chief, Division of Gastroenterology | Leading medical school with a strong emphasis on GI research and clinical innovation. |
| 11 | Merck & Co. | https://www.merck.com/ | Group Head, GI Oncology | Pharmaceutical company with research interests in gastrointestinal cancers. |
| 12 | University of Cambridge | https://www.cam.ac.uk/ | Lecturer in Gastroenterology | Renowned academic institution contributing to advancements in GI science. |
| 13 | Janssen Pharmaceuticals | https://www.janssen.com/ | Medical Director, GI Therapeutics | Pharmaceutical company with a portfolio of GI treatments and research initiatives. |
| 14 | Yale University School of Medicine | https://medicine.yale.edu/ | Director, Gastroenterology Section | Prominent medical school with active research and clinical programs in gastroenterology. |
| 15 | AbbVie Inc. | https://www.abbvie.com/ | Senior Scientist, GI Inflammation | Biopharmaceutical company focused on developing treatments for inflammatory GI conditions. |
| 16 | University of Toronto | https://www.utoronto.ca/ | Professor, Department of Medicine (Gastroenterology) | Leading Canadian university with significant research output in gastrointestinal diseases. |
| 17 | Medtronic PLC | https://www.medtronic.com/ | Product Manager, GI Devices | Medical technology company offering devices for gastrointestinal diagnostics and treatment. |
| 18 | Harvard Medical School | https://hms.harvard.edu/ | Chair, Gastroenterology Division | Prestigious medical school with extensive research and clinical expertise in GI health. |
| 19 | Sanofi | https://www.sanofi.com/ | Research Director, GI Metabolic Disorders | Global pharmaceutical company with interests in gastrointestinal and metabolic diseases. |
| 20 | University of Melbourne | https://www.unimelb.edu.au/ | Head, Department of Gastroenterology | Leading Australian university with research and clinical programs in gastroenterology. |
Job Profiles, Industries, and Event Type
Best Job Profiles to Target:
- Gastroenterologists
- Hepatologists
- Clinical Researchers
- Academicians
- Healthcare Practitioners
- Research Scientists
- Medical Directors
- Product Development Managers (Medical Devices/Pharmaceuticals)
- Professors/Lecturers in Gastroenterology
- Heads of Departments (Gastroenterology/Hepatology)
Industries:
- Healthcare
- Pharmaceuticals
- Biotechnology
- Medical Devices
- Academic Research
- Hospitals & Clinics
- Healthcare Education
Event Type: Hybrid Conference (In-person and Virtual)
Estimated Attendance
The estimated attendance for the 2nd Edition of the International Conference on Gastroenterology is not explicitly stated on the official website. However, given the global reach and hybrid format, it is expected to attract a significant number of participants, including:
- Gastroenterologists and Hepatologists
- Clinical Researchers and Academicians
- Healthcare Practitioners
- Pharmaceutical and Medical Device Industry Professionals
- Students and Trainees in Gastroenterology
Key Focus Areas and Buyer Engagement
Key Focus Areas:
- Inflammatory Bowel Disease
- MASLD/NAFLD & Metabolic Liver Disease
- Therapeutic / Advanced Endoscopy
- Gut–Brain Axis & Functional GI Disorders
- Microbiome Science, Nutrition & Probiotics
- AI, Digital Health & Data Science for GI Care
- Diagnostic Endoscopy & Quality Standards
- Pancreatic Disorders
- Esophagus & Reflux Disorders
- Viral Hepatitis & Liver Infections
- Liver Cancer & Advanced Hepatobiliary Oncology
- Liver Transplantation & Post-Transplant Care
- Pediatric Gastroenterology & Hepatology
- GI Bleeding & Emergency Endoscopy
- Precision Gastroenterology & Future Technology
- Colorectal Cancer Screening, Prevention & Polyp Management
Buyer Engagement Angle: The event offers a unique opportunity for companies and organizations to engage with key decision-makers in the field of gastroenterology. By participating, businesses can:
- Present innovative products and research to a targeted audience.
- Network with potential collaborators and clients.
- Stay updated on the latest advancements and trends in gastroenterology.
- Enhance brand visibility within the global gastroenterology community.
Client Product Fit Note
To provide a tailored list of potential buyers based on your specific product or service, please share your client's website. This will allow us to align the buyer profiles with your offerings, ensuring maximum relevance and engagement opportunities at the 2nd Edition of the International Conference on Gastroenterology.
Final Recommendation
The 2nd Edition of the International Conference on Gastroenterology is a valuable event for companies and organizations looking to engage with professionals in the field. With its global reach, hybrid format, and focus on cutting-edge research and innovation, it presents a prime opportunity for networking, collaboration, and business development. We recommend participating in this event to connect with key stakeholders and stay at the forefront of advancements in gastroenterology.
Industry Suggestions Based on Event Focus
Based on the event's focus areas, the following industries are particularly relevant:
- Healthcare
- Pharmaceuticals
- Biotechnology
- Medical Devices
- Academic Research
- Hospitals & Clinics
- Healthcare Education
Data sheet
2nd Edition of International Conference on Gastroenterology – Event Attendee & Buyer Profile Analysis
Event date: September 24–26, 2026
Location: Delta Hotels Heathrow Windsor, London, United Kingdom
Event status: Upcoming
Research date: June 30, 2026
Event Overview
| Event Name | 2nd Edition of International Conference on Gastroenterology |
| Event Date | September 24–26, 2026 |
| Event Status | Upcoming |
| Venue | Delta Hotels Heathrow Windsor |
| City | London |
| State / Region | England |
| Country | United Kingdom |
| Organizer | Magnus Group |
| Official Event Website | gastroenterology.magnusconferences.com |
| Event Type | Hybrid conference (in-person and virtual) |
| Primary Category | Medical & Pharma |
| Secondary Applicable Categories | Science & Research; Wellness, Health & Fitness |
| Audience Reach | Global |
| Estimated Attendance / Expected Footfall | Attendance figure not publicly confirmed by the organizer. |
| Attendance Data Reliability | Low for attendee volume; official website confirms event format, date, city, venue, and participant profile, but not attendee count. |
| Main Purpose of Event | Medical education, scientific exchange, research presentation, clinical collaboration, and professional networking in gastroenterology, hepatology, digestive diseases, endoscopy, and GI innovation. |
About the Event
The 2nd Edition of International Conference on Gastroenterology is a hybrid medical conference scheduled for September 24–26, 2026 in London, United Kingdom, with virtual participation available globally. According to the official event website, the conference centers on “Global Perspectives in Gastroenterology: Innovation to Impact” and covers scientific sessions spanning inflammatory bowel disease, liver disease, advanced endoscopy, gut-brain disorders, microbiome science, AI in GI care, pancreatic disorders, colorectal cancer screening, pediatric gastroenterology, and hepatobiliary oncology.
From a commercial and lead-generation perspective, this is primarily a professional congress rather than a high-volume trade exhibition. Its value lies in access to clinicians, researchers, academic institutions, hospital-based specialists, and healthcare innovation stakeholders who influence adoption of medical technologies, diagnostics, research partnerships, education programs, and specialty-care solutions. It is most relevant for targeted B2B outreach into specialist healthcare and research audiences rather than broad attendee-list volume sales.
1. Who Attends: Buyers / Attendees
| Buyer / Attendee Segment | Typical Organizations | Buying Role or Influence | Relevance to Exhibitors / Suppliers |
|---|---|---|---|
| Gastroenterologists | Hospitals, GI clinics, academic medical centers | Clinical decision influence on diagnostics, endoscopy, therapeutics, care pathways | High relevance for medical devices, diagnostics, pharmaceuticals, CME, and digital health suppliers |
| Hepatologists | Liver centers, teaching hospitals, specialty practices | Strong influence over liver diagnostics, treatment protocols, and specialty referrals | High relevance for liver disease solutions, imaging, testing, treatment support, and research partnerships |
| Clinical researchers | Universities, hospitals, research institutes, trial networks | Influence over study partnerships, grant collaborations, data platforms, and trial tools | High relevance for CROs, research software, lab services, and academic collaboration vendors |
| Academicians | Medical schools, universities, teaching hospitals | Influence over curriculum, research direction, conference partnerships, and institutional adoption | Relevant for education technology, publications, research tools, and institutional outreach |
| Healthcare practitioners | Clinics, hospitals, ambulatory centers, specialty practices | Operational and user-level influence on adoption of clinical tools and services | Relevant for workflow platforms, patient engagement tools, devices, and training solutions |
| Endoscopy and GI procedure leaders | Endoscopy units, hospital GI departments | Influence over procedural standards, quality metrics, device selection, and service models | Very relevant for endoscopy suppliers, sterilization, imaging, and quality-management solutions |
| Digital health and AI stakeholders in GI care | Hospitals, health-tech firms, academic research groups | Influence over software evaluation, analytics adoption, and innovation pilots | Relevant for AI imaging, clinical decision support, interoperability, and data platforms |
| Medical industry partners and scientific solution providers | Medical device firms, pharma companies, diagnostics providers, CROs | Business development, KOL engagement, partnership evaluation | Relevant for sponsorship, scientific visibility, product awareness, and pipeline building |
2. Event Location and Attendee Geographic Origin
| Geographic Area | Likely Attendee Origin | Buyer Concentration | Notes |
|---|---|---|---|
| Host city | London metropolitan medical and academic community | High | London supports strong concentration of teaching hospitals, research institutions, and specialist clinics. |
| Host state / region | England and South East healthcare networks | High | Venue near Heathrow improves accessibility for domestic and regional attendees. |
| Nearby business hubs | Slough, Greater London, Oxford-Cambridge-London academic corridor | Medium to High | Relevant for medical research, pharma access, med-tech partnerships, and conference travel convenience. |
| National reach | United Kingdom-wide clinicians, researchers, and institutions | Medium | Official hybrid format broadens access beyond onsite participation. |
| International reach | Europe, North America, Asia, and other virtual participants | High | Official website explicitly positions the event as a hybrid global conference. |
| Key trade / referral corridors | UK-EU clinical research collaboration and transatlantic academic participation | Medium | Most relevant for scientific exchange, speaking engagements, and research-led B2B partnerships rather than mass procurement. |
3. Audience Reach
| Reach Level | Assessment | Explanation |
|---|---|---|
| Global | Primary classification | The organizer describes the conference as a hybrid event in London, UK with virtual attendance from anywhere, indicating cross-border accessibility and international participant intent. |
| Regional / European | Secondary practical reach | London location and Heathrow-adjacent venue make the event especially accessible to UK and European delegates for in-person participation. |
4. Sample Buyer Companies and Websites
Official current-year attendee, exhibitor, sponsor, and buyer organization lists were not publicly visible in the source material reviewed. The table below therefore includes only verifiable current-year organization evidence from the official conference website. This is not a comprehensive attendee list and should not be treated as one.
| Buyer Company / Organization | Buyer Type | Why It Is Relevant | Website | Best Job Titles to Target | Evidence Level |
|---|---|---|---|---|---|
| University of Florida | Academic medical / research institution | Listed on the official website through a committee member affiliation, indicating current-year organizational presence in the conference ecosystem. | ufl.edu | Professor of Gastroenterology, Clinical Research Director, GI Program Director, Department Chair | Confirmed Speaker Organization |
5. Job Profiles, Industries and Event Type
| Priority | Job Title / Function | Department | Seniority Level | Why This Role Matters |
|---|---|---|---|---|
| 1 | Head of Gastroenterology | Clinical / Medical | Director / Head | Department leaders influence clinical adoption, referrals, procurement input, and partnership decisions. |
| 2 | Gastroenterologist | Clinical / Medical | Manager / Individual Contributor | Core specialty audience with direct user insight and high influence over GI technology and treatment selection. |
| 3 | Hepatologist | Clinical / Medical | Manager / Individual Contributor | Important for liver disease diagnostics, therapeutics, trial participation, and specialty-care solutions. |
| 4 | Director of Endoscopy | Clinical Operations | Director | Relevant for procedure equipment, imaging, workflow, safety, and quality-standard purchases. |
| 5 | Clinical Research Director | Research | Director | Key for studies, trials, data collection tools, and research collaboration opportunities. |
| 6 | Professor / Associate Professor of Gastroenterology | Academic / Research | Senior | Influences scientific credibility, speaking visibility, and institutional introductions. |
| 7 | Digital Health Director | Innovation / IT | Director | Relevant due to official AI, digital health, and data science session coverage. |
| 8 | Procurement Manager, Medical Devices | Procurement / Supply Chain | Manager | Less visible than clinicians at congresses, but essential for formal purchase conversion in hospitals and clinics. |
| 9 | Medical Affairs Director | Medical Affairs | Director | Important for pharma, diagnostics, and scientific communications partnerships. |
| 10 | Business Development Director, Clinical Partnerships | Business Development | Director | Relevant for commercialization, institutional pilots, and research alliance development. |
| Priority | Apollo Industry | Why It Fits the Event | Best Buyer Use Case |
|---|---|---|---|
| 1 | Hospital & Health Care | Core clinical attendance base for GI and liver care | Hospital departments, specialty centers, physician leaders |
| 2 | Medical Practice | Relevant for specialist GI clinics and physician groups | Outpatient GI providers, private specialty practices |
| 3 | Research | Conference emphasizes scientific presentations and knowledge exchange | Research institutes, trial groups, translational science teams |
| 4 | Higher Education | Academic physicians and universities are central to participation | Medical schools, university hospitals, faculty-led programs |
| 5 | Pharmaceuticals | GI and hepatology topics align with treatment development and medical affairs outreach | Therapy education, KOL mapping, scientific engagement |
| 6 | Medical Devices | Direct relevance to endoscopy, diagnostics, and procedural innovation | Device marketing, physician adoption, clinical validation |
| 7 | Biotechnology | Relevant for precision gastroenterology, biomarkers, and translational research | R&D collaboration and investigator engagement |
| 8 | Information Technology & Services | AI, digital health, and data science are official scientific topics | Clinical software, analytics, interoperability, digital care tools |
| 9 | Computer Software | Useful for vendors serving hospitals and clinical researchers | GI workflow, imaging review, patient data, trial management |
| 10 | Health, Wellness & Fitness | Relevant for digestive health, nutrition, and preventative care solutions | Nutrition-focused programs, patient engagement, wellness tools |
6. Estimated Attendance
| Metric | Figure | Status | Source / Basis | Notes |
|---|---|---|---|---|
| Estimated total footfall | Attendance figure not publicly confirmed by the organizer. | Unconfirmed | Official event website reviewed | No official attendee count found in the provided source material. |
| Exhibitor count | Not publicly confirmed | Unconfirmed | Official event website reviewed | Event appears conference-led rather than exhibitor-led in the material reviewed. |
| Buyer count | Not publicly confirmed | Unconfirmed | Official event website reviewed | The conference promotes attendee types but not a quantified buyer breakdown. |
| Speaker count | Not publicly confirmed | Unconfirmed | Official website has dedicated speakers and committee sections | Presence of speakers and committee is confirmed; total count was not visible in source text. |
| Sponsor count | Not publicly confirmed | Unconfirmed | Official event website reviewed | No sponsor list was visible in the provided official content. |
| Historical attendance | Not available from source material reviewed | Historical / prior-year evidence unavailable | Prior-year navigation is visible, but no attendance data was present in the supplied content | No verified prior-year footfall figure should be assumed. |
7. Key Focus Areas and Buyer Engagement
| Focus Area | Typical Buyer Need | Buyer Engagement Opportunity | Relevant Supplier Offering |
|---|---|---|---|
| Inflammatory bowel disease | Therapy optimization, diagnostics, care pathways | Clinical education, KOL engagement, evidence-based solution positioning | Diagnostics, pharma support, patient monitoring tools |
| MASLD/NAFLD and metabolic liver disease | Screening, risk stratification, therapeutic innovation | Target hepatology leaders and research programs | Liver diagnostics, disease-management platforms, therapeutics |
| Therapeutic / advanced endoscopy | Procedure efficiency, visualization quality, device performance | Product demos, physician relationships, procedural training | Endoscopy devices, imaging, accessories, workflow systems |
| Microbiome science, nutrition and probiotics | Evidence-backed interventions and translational research | Partnerships with academics and specialty practitioners | Research platforms, nutrition science, wellness and patient-engagement tools |
| AI, digital health and data science for GI care | Automation, analytics, decision support, quality improvement | Innovation pilots, software demos, hospital partnership development | Clinical AI, analytics, software, interoperability solutions |
| Colorectal cancer screening and prevention | Screening compliance, early detection, quality standards | Engage GI leaders, screening program managers, and academic centers | Diagnostics, screening technology, awareness programs |
| Pediatric gastroenterology and hepatology | Specialized care protocols and pediatric treatment pathways | Niche outreach to children's hospitals and academic specialists | Pediatric-focused devices, diagnostics, and clinical education |
| Liver transplantation and post-transplant care | Specialty monitoring, patient management, multidisciplinary coordination | High-value specialist networking and institution-level engagement | Monitoring tools, software, care management, clinical services |
Lead Quality Assessment
| Factor | Assessment | Explanation |
|---|---|---|
| Buyer relevance | High | Highly relevant for medical, clinical, research, and specialty-care solutions aligned with gastroenterology and hepatology. |
| Decision-maker availability | Medium | Strong clinical influence is expected, but direct procurement officials may be less visible than physician leaders at this type of conference. |
| Data collection potential | Medium | Good for speaker, committee, and topic-led account mapping; weaker for broad official attendee-list extraction based on currently public information. |
| Apollo targeting potential | High | Specialty hospitals, academic centers, research institutions, med-tech, and pharma audiences can be targeted effectively in Apollo. |
| Geographic targeting potential | High | London, UK, Europe, and global hybrid reach allow layered geo-targeting strategies. |
| Best outreach approach | High | Use topic-led outreach around GI innovation, liver disease, endoscopy, AI in GI, and academic collaboration rather than generic event sales language. |
| Overall lead quality | High | Strong fit for niche healthcare, research, and med-tech offerings; lower fit for general business services or non-medical products. |
| Best use case | High | Ideal for targeted account-based marketing, speaker-affiliation prospecting, KOL mapping, and specialist outreach. |
| Limitations / risks | Medium | Not ideal for high-volume attendee list building unless broader official directories become available. Publicly confirmed buyer-company evidence is currently limited. |
Apollo.io Targeting Recommendation
| Filter Type | Recommended Filters | Purpose |
|---|---|---|
| Apollo industries | Hospital & Health Care; Medical Practice; Research; Higher Education; Pharmaceuticals; Medical Devices; Biotechnology; Information Technology & Services; Computer Software; Health, Wellness & Fitness | Build a focused account universe around GI care, research, and enabling technology |
| Departments | Medical; Clinical Research; Operations; Innovation; Information Technology; Procurement; Business Development; Medical Affairs | Reach both clinical influencers and commercial adoption stakeholders |
| Seniority | Director; VP; Head; CXO; Partner; Senior; Manager | Prioritize decision-makers and senior specialists with budget or influence |
| Job titles | Head of Gastroenterology; Gastroenterologist; Hepatologist; Director of Endoscopy; GI Program Director; Clinical Research Director; Professor of Gastroenterology; Medical Affairs Director; Digital Health Director; Procurement Manager, Medical Devices; Business Development Director | Mirror likely attendee and influence profiles from the conference theme and sessions |
| Geography | United Kingdom; London; England; Western Europe; United States; Canada; India; Singapore; Australia | Align with hybrid international medical conference reach |
| Employee size | 51–200; 201–500; 501–1,000; 1,001–5,000; 5,001–10,000; 10,001+ | Capture specialty clinics, academic centers, hospital systems, and enterprise healthcare organizations |
| Keywords | gastroenterology, hepatology, endoscopy, digestive health, GI, IBD, liver disease, microbiome, colorectal screening, pancreatic disorders, clinical research, digital health, AI in healthcare | Improve title and company matching for niche specialty segments |
| Technologies, if relevant | Clinical analytics, AI imaging, telehealth, EHR interoperability, research data management | Useful for digital health or software suppliers serving GI and hospital buyers |
| Revenue range, if relevant | $10M–$50M; $50M–$250M; $250M–$1B; $1B+ | Useful for prioritizing well-funded healthcare and med-tech accounts |
| Company type | Hospitals; Academic institutions; Research institutes; Specialty clinics; Med-tech firms; Pharma companies | Supports account segmentation by care delivery, research, and commercialization models |
Suggested Apollo Search Logic: ("gastroenterology" OR "hepatology" OR "digestive health" OR "GI" OR endoscopy OR "liver disease" OR IBD OR microbiome OR "colorectal screening") AND (Director OR Head OR VP OR Professor OR Manager) AND (hospital OR clinic OR university OR research OR medical device OR pharma).
Client Fit Review Required
Please share the client website or product/service details. I will review the client offering and identify the highest-fit buyer companies, Apollo industries, seniority levels, departments, and job titles from this event.
Sources & Verification Notes
| Source | Type | What It Verified | Reliability |
|---|---|---|---|
| Gastroenterology 2026 Official Event Website | Official event website | Confirmed event name, dates, London location, hybrid format, venue name, venue address, scientific theme, attendee profile, scientific sessions, abstract deadline, early bird date, and committee-member organization evidence. | High |
| Program / Scientific Sessions Navigation on Official Website | Official event section | Validated event positioning as a scientific conference focused on research presentations, workshops, and GI specialty topics rather than a broad trade expo. | High |
| Speakers / Committee Sections on Official Website | Official speaker and committee sections | Provided limited current-year organization evidence, including University of Florida affiliation shown in the supplied official content. | Medium to High |
| Verification note | Research limitation | No public current-year attendee count, exhibitor count, sponsor directory, or full buyer list was visible in the source material reviewed. This report therefore separates confirmed facts from likely attendee profiling. | High |
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to 2nd Edition of International Conference on Gastroenterology — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
🔒 Get my buyer details Free · ~20 seconds